Vijay Modur's most recent trade in Eloxx Pharmaceuticals Inc was a trade of 30,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Jan. 25, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Eloxx Pharmaceuticals Inc | Vijay Modur | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
Eloxx Pharmaceuticals Inc | Vijay Modur | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 496,204 | 496,204 | - | - | Stock Options (Right to Buy) |